Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (551-560 of 4,678) with videos related to

Pageof 468
Sort By:
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
Cancer Discovery|May 10, 2013
Two drugs deemed breakthrough therapies
Cancer Discovery|May 10, 2013
Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancerRon Chen, E Alejandro Sweet-Cordero
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Cancer Discovery|April 3, 2013
GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κBDeepali Bang, Willie Wilson, Meagan Ryan, et al.
Cancer Discovery|April 4, 2013
The basic principles of chimeric antigen receptor designMichel Sadelain, Renier Brentjens, Isabelle Rivière
Cancer Discovery|March 5, 2013
Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancerMiriam Molina-Arcas, David C Hancock, Clare Sheridan, et al.
Cancer Discovery|February 13, 2013
Mitotic control of cancer stem cellsMonica Venere, Tyler E Miller, Jeremy N Rich
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Cancer Discovery|March 12, 2013
Q&A: Rajeshwari Sridhara, Robert Temple on trial design. Interviewed by Suzanne RoseRajeshwari Sridhara, Robert Temple
Pageof 468

Showing results (551-560 of 4,678) with videos related to

Sort By:
Pageof 468
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
Cancer Discovery|May 10, 2013
Two drugs deemed breakthrough therapies
Cancer Discovery|May 10, 2013
Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancerRon Chen, E Alejandro Sweet-Cordero
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Cancer Discovery|April 3, 2013
GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κBDeepali Bang, Willie Wilson, Meagan Ryan, et al.
Cancer Discovery|April 4, 2013
The basic principles of chimeric antigen receptor designMichel Sadelain, Renier Brentjens, Isabelle Rivière
Cancer Discovery|March 5, 2013
Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancerMiriam Molina-Arcas, David C Hancock, Clare Sheridan, et al.
Cancer Discovery|February 13, 2013
Mitotic control of cancer stem cellsMonica Venere, Tyler E Miller, Jeremy N Rich
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Cancer Discovery|March 12, 2013
Q&A: Rajeshwari Sridhara, Robert Temple on trial design. Interviewed by Suzanne RoseRajeshwari Sridhara, Robert Temple
Pageof 468